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 Sleep misperception – the discrepancy between objective and subjective measures of 
sleep – has been shown to be prevalent among patients with insomnia and may be a promising 
target for sleep intervention.  This study examined sleep misperception in a diverse outpatient 
medical sample using consumer-grade wearable actigraphs (i.e., Fitbit Charge HR™).  Forty-
four self-identified problem sleepers aged 20 to 79 participated in the study.  Participants 
completed sleep diaries for one week while also tracking their sleep using the Fitbit Charge 
HR™.  After receiving a personalized sleep report based on these data, participants repeated 
another week of sleep assessment.  Sleep misperception was observed for both total sleep time 
and sleep onset latency during the first week, such that participants underestimated their total 
amount of sleep per night and overestimated the amount of time it took them to fall asleep.  Pre-
post changes in self-reported sleep, mood, and health were examined as a secondary aim in this 
study.  Objectively measured sleep remained relatively unchanged from baseline to follow-up.  
Despite this lack of change in actual sleep, participants perceived themselves to be sleeping more 
hours per night, falling asleep more quickly, and sleeping better overall at one-week follow-up.  
Statistically significant improvements in depression, anxiety, mental health functioning, and 
insomnia symptom severity were also observed at follow-up.  Overall, findings showed that 
sleep misperception is prevalent among problem sleepers and that sleep discrepancy can be 
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Sleep problems are ubiquitous in the modern world and present a significant public health 
concern (Matricciani et al., 2017; Pallesen et al., 2014).  Self-reported sleep problems are 
associated with higher stress levels, lower life satisfaction, and worse health outcomes (NSF, 
2014).  More than one-third of U.S. adults sleep less than the 7 hour per night minimum 
recommended by the National Sleep Foundation (CDC, 2011), consequences of which are well-
documented (Itani et al., 2017).  Acute sleep insufficiency has been linked to inflammation 
(Irwin, Olmstead, & Carroll, 2016), decreased insulin sensitivity (Czeisler, 2015; van Cauter et 
al., 2007), and immunosuppression (Cohen et al., 2009; Prather et al., 2015), whereas, chronic 
insufficient sleep has been associated with increased risk for cardiovascular disease (Bhaskar, 
Hemavathy, & Prasad, 2016; Taylor et al., 2007), coronary heart disease (Itani et al., 2017), 
hypertension (Bathgate et al., 2016), diabetes mellitus (Shan et al., 2015), and obesity (Itani et 
al., 2017).   
Also associated with short duration sleep are impairments in executive functioning 
(Kuula et al., 2017), memory consolidation (Gildner et al., 2014; Prince & Abel, 2013), and 
attention (Ahmad & Bashir, 2017; Perez-Lloret et al., 2013).  Sleep insufficiency is also 
associated with increased risk for mild cognitive impairment (MCI), dementia (Chen et al., 
2016), and cognitive decline in older adults (Lo et al., 2014).  Much research has been done on 
the impact of sleep disturbance and insufficiency on mood and affective functioning, finding it to 
contribute to depression and anxiety as well as more global emotion dysregulation (Coulombe et 
al., 2011; Pasch et al., 2010; Watling et al., 2017).   
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Taken together, it is clear that sleep impairment has a significant negative impact on 
health and wellbeing.  It is important to note that this relationship is bi-directional, such that 
those with poor health (medical and psychosocial functioning) are also more likely to develop 
sleep problems (Mai & Buysse, 2008).  Given this reciprocity between sleep and health, it is no 
surprise that sleep complaints are prevalent in medical settings.  Sleep problems are often first 
identified by primary care providers (Edinger & Sampson, 2003; Qaseem et al., 2016; van der 
Zweerde et al., 2016).  An estimated 20-50% of primary care patients meet full diagnostic 
criteria for insomnia (Bjorvatn, Meland, Flo, & Mildestvedt, 2017; Trauer, Qian, Doyle, 
Rajaratnam, & Cunningham, 2015; Troxel & Buysse, 2013) and as many as 55% of those 
without clinical insomnia report subthreshold sleep problems (Bjorvatn, Meland, Flo, & 
Mildestvedt, 2017).  Overall, findings suggest that a large majority of adults experience some 
degree of sleep difficulty or impairment, with as few as 10% reporting no sleep problems 
(Bjorvatn, Meland, Flo, & Mildestvedt, 2017).  Further, the rate of sleep problems has increased 
significantly over the past two decades and continues to rise, according to epidemiological 
studies (Calem et al., 2012; Pallesen et al., 2014). 
With mounting evidence for its’ pervasive impact on health, sleep has garnered both 
empirical and clinical attention in recent years.  In fact, the importance of sleep is so widely 
recognized that the National Sleep Foundation (NSF) recommends including it as a vital sign in 
routine medical care (Grandner & Malhotra, 2015; Ojile, 2017).  To date, researchers have 
extensively explored sleep disorders and related problems, including development and 
maintenance factors (e.g., biological, psychological, social, behavioral), assessment and 
measurement (e.g., polysomnography, actigraphy), current intervention and treatment (e.g., 
pharmacological, cognitive and behavioral), and other potential treatment targets (i.e., sleep 
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misperception).  The following literature review will describe the research within each of the 
listed domains broadly then will explore areas relevant to the present study in greater depth.  
Specifically, the concept of sleep misperception will be introduced and discussed in relation to 
sleep impairment and health.  The present study, which examined sleep misperception as a 
clinical symptom and as an intervention target among medical patients, will then be presented 






Insomnia is the most common sleep disorder, with prevalence estimates ranging broadly 
from 10% to more than 50% worldwide (Bjorvatn et al., 2017; Ohayon & Reynolds, 2009; 
Pallesen et al., 2014; Terzano et al., 2004).  This observed discrepancy in prevalence rates is 
largely believed to be the result of variability in diagnostic criteria across the three major 
classification systems used to diagnose insomnia: International Classification of Sleep Disorders 
– Third Edition (ICSD-3; AASM, 2014), International Statistical Classification of Diseases and 
Related Health Problems – Tenth Revision (ICD-10; World Health Organization, 1992), and 
Diagnostic and Statistical Manual of Mental Disorders – Fifth Edition (DSM-5; APA, 2013).  
See Table 1. 
In order to diagnose insomnia, all three diagnostic manuals require: (1) self-reported 
sleep disturbance or difficulty, (2) which causes some form of functional impairment or distress, 
(3) despite adequate opportunity and circumstances for sleep.  Despite these commonalities, the 
minimum frequency and duration of symptoms required for an insomnia diagnosis varies across 
each of the classification systems.  This is problematic in terms of estimating prevalence rates 
and interpreting research in the sleep field, as these findings are based on disparate diagnostic 
criteria.  Moreover, recent updates to these manuals and their respective classification systems 
further compound this diagnostic problem.  These diagnostic inconsistencies have sparked debate 
amongst sleep researchers, many of whom argue that insomnia may be better understood as 
dimensional rather than categorical (Ohayon & Reynolds, 2009).  Much of the research included 
in this literature review has relied on a clinical diagnosis of insomnia as categorized by one of 
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the aforementioned diagnostic manuals; therefore, the term “insomnia” will be used inclusively 
for all three classification systems for simplicity. 
Table 1. Insomnia diagnostic criteria 
 




Difficulty initiating sleep, maintaining sleep (frequent awakenings or 
difficulty returning to sleep after awakenings), waking up earlier than 
desired with an inability to return to sleep 
 
Difficulty initiating or 
maintaining sleep, or 
nonrestorative sleep 
Consequence(s) One or more of the following related to 
the nighttime sleep difficulty: 
1. Fatigue/malaise 
2. Attention, concentration, or memory 
impairment 
3. Impaired social, family, occupational, 
or academic performance 
4. Mood disturbance, irritability 
5. Daytime sleepiness 
6. Behavioral problems (e.g., 
hyperactivity, impulsivity, aggression) 
7. Reduced motivation, energy, initiative 
8. Proneness for errors, accidents 
9. Concerns about or dissatisfaction with 
sleep 
Clinically significant 
distress or impairment in 
social, occupational, 
educational, academic, 
behavioral, or other 
important areas of 
functioning 
 
Frequency Sleep disturbance occurs at least 3 times per week  No minimum 
Duration ≥ 3 months (Chronic) 
< 3 months (Short-Term) 
At least 3 months At least 1 month 




Sleep difficulties are not better explained by another sleep disorder, psychological disorder, or 
medical condition and are not attributed to the physiologic effects of a substance 
Development and Course 
Spielman’s 3P Model of Insomnia (Table 2) is one of the most widely recognized models 
for the development and maintenance of insomnia, offering an integrated explanation and 
framework for insomnia and its’ multiple determinants (Spielman, 1986; Williams, Roth, 
Vatthauer, & McCrae, 2013).  Briefly, this model asserts that individuals who develop insomnia 
possess predisposing factor(s) that make them susceptible to the disorder (i.e., biological or 
psychological characteristics that increase one’s vulnerability for developing sleep problems).  
When exposed to a precipitating event, such as an illness or life stressor, these individuals are at 
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increased risk for developing acute insomnia symptoms.  For some, these symptoms will be 
time-limited and will remit when the stressor is removed, whereas others will develop 
maladaptive responses such as problematic behaviors, thoughts, or beliefs about sleep which will 
serve as the perpetuating mechanisms that maintain the sleep disturbance and lead to chronic or 
more severe sleep problems. 
Table 2. Spielman’s 3P Model of Insomnia 
 Definition Examples 
Predisposing 
factors 
Biological and psychological factors 
that increase risk of developing a sleep 
disorder  




Situational, medical, psychosocial, and 
environmental triggers for sleep 
problems 




Behaviors and thoughts or beliefs that 
exacerbate or perpetuate sleep problems 
alcohol use, naps, extending time 
in bed, worry about ability to 
sleep, fear of sleeplessness 
   
Spielman’s model aptly illustrates the negative cascade of events that leads to the 
development of more complex and severe sleep problems.  Notably, these factors are largely 
modifiable.  As such, early identification of patients with sleep problems offers a golden 
opportunity for prevention and may allow for early intervention to minimize the negative impact 
of acute sleep disturbance and prevent the development of chronic sleep problems.  
Sleep Measurement 
Polysomnography (PSG) is the current gold standard measure in sleep assessment (Kapur 
et al., 2017).  Broadly, PSG provides a measure of sleep architecture, including sleep continuity, 
neural activity, and time spent in each stage of sleep (Kapur et al., 2017; Togeiro & Smith, 
2005).  It is typically conducted in a sleep laboratory for a period of one night.  PSG is used 
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primarily to diagnose breathing-related sleep conditions, such as Obstructive Sleep Apnea (OSA; 
Kapur et al., 2017; Ong, Arnedt, & Gehrman, 2017).  Though PSG is the gold standard, it is 
costly and impractical as a tool for assessing insomnia in routine clinical settings.  A major 
limitation of traditional PSG is that patients are required to complete an overnight sleep study in 
a laboratory setting.  Not only is this often aversive to patients but sleep patterns are also likely 
to be influenced by the lab environment itself and may not be representative of a patient’s typical 
sleep patterns at home (Nissen et al., 2015).   
One alternative to the traditional lab-based sleep study is ambulatory (or portable) PSG.  
A major benefit of ambulatory PSG is that it can be completed independently in the home, 
thereby reducing patient burden and the risk of environmental influence on sleep recordings 
(Kapur et al., 2017).  Patients are provided a portable monitor which records blood oxygenation 
levels, airflow, and respiratory effort, at minimum.  Sleep is recorded for one or more nights and 
data is extracted by a sleep technician or specialist for interpretation.  The Portable Monitoring 
Task Force of the American Academy of Sleep Medicine recommends that it be used when 
moderate to severe OSA is suspected and no other sleep disorders are present or suspected 
(Collop et al., 2007).  Though ambulatory PSG addresses some of the limitations of traditional 
PSG, it is not a viable option for insomnia assessment in routine clinical practice. 
Actigraphy is a more economical and accessible option that can be more readily 
integrated into clinical practice to objectively evaluate sleep problems.  Actigraphy uses 
accelerometer technology to measure bodily movement.  Specifically, triaxial accelerometry 
measures movement on three planes which is interpreted as a proxy for sleep disturbance.  
Actigraphs may be worn on the wrist or ankle and are typically the approximate size of a 
wristwatch.  Research- and medical-grade actigraphy has been found to have good agreement 
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(90%) with PSG and high sensitivity (90- 95%; Sadeh, 2011; Rupp & Balkin, 2011) for detecting 
a sleep state, though specificity is lower (50-65%) for detecting awakenings (Rupp & Balkin, 
2011).  Though it is not a replacement for PSG, actigraphy can be used to characterize sleep and 
circadian patterns and to evaluate response to treatment (Buysse et al., 2010; Kay et al., 2015).  
In fact, actigraphy (research/medical grade) is now listed in the Federal Register as an approved 
method of assessment for patients with insomnia symptoms (minimum of 72 hours to 14 
consecutive days of recording).  It is recommended that patients complete a sleep log in 
conjunction with actigraphy to provide a more comprehensive clinical picture (sleep diary entry 
examples: lights off, lights on, out of bed, actigraph off for shower, estimated TST, sleep 
latency) (Federal Register).   
Commercially available actigraphs have also increased in popularity over the past several 
years and produce enormous amounts of patient-generated health data (PGHD).  Despite their 
widespread use, these devices and their resultant PGHD are not widely used in clinical practice.  
Though many healthcare providers are eager to incorporate this data into assessment and 
treatment planning, no guidelines currently exist.  Research is burgeoning in this area but is 
largely still in its’ infancy.  Recent research has examined the concordance of sleep data derived 
from various consumer activity monitors compared to research- and medical-grade actigraphs 
and PSG (de Zambotti, Baker, & Colrain, 2015; de Zambotti et al., 2016; Mantua, Gravel, & 
Spencer, 2016).   
One validation study compared a commercially available actigraph (Jawbone UP™) to 
PSG in a sample of 65 healthy individuals between the ages of 12 and 22 (de Zambotti, Baker, & 
Colrain, 2015).  This study found good agreement between measures for total sleep time (85% 
within range) and wake after sleep onset (89% within range), based on a priori determined limits, 
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but found the Jawbone UP™ to overestimate sleep efficiency and underestimate wake after sleep 
onset (de Zambotti, Baker, & Colrain).  Similar results were found for four other commercially 
available actigraphs (Basis Health Tracker, Misfit Shine, Fitbit Flex, Withings Pulse O2) when 
compared to the Actiwatch Spectrum research-grade actigraph and PSG among a sample of 40 
healthy young adults (Mantua, Gravel, & Spencer, 2016).  This study found strong correlations 
between PSG and all actigraph devices for TST (r=0.84-0.97, p<0.05), with the Fitbit Flex 
(r=0.97) being most strongly correlated with PSG (Mantua, Gravel, & Spencer, 2016).  In a 
validation study of the Fitbit Charge HR™ researchers employed a third-party research platform 
(Fitabase™) for data collection, which allowed them to examine sleep data in 60-second epochs, 
similar to research-grade actigraph output (de Zambotti et al., 2016).  The Fitbit Charge HR™ 
was found to have high overall agreement with PSG (91% within range) and high sensitivity 
(97%) for detecting sleep.  Similar to validation studies with research-grade actigraphs, 
specificity for detecting wake (42%) was found to be low for the Fitbit Charge HR™ (de 
Zambotti et al., 2016).  
Findings to date indicate that many commercially available actigraphs have good 
agreement with PSG for TST and have similar sensitivity and specificity to research- and 
medical-grade actigraph devices (Baron et al., 2018).  Taken together, these findings suggest that 
commercial actigraphs may be a promising tool in sleep assessment and warrant further 
exploration, both for evaluative and intervention purposes.  
Treatment 
Cognitive Behavioral Therapy for Insomnia (CBT-I) is the current gold-standard 
treatment recommended by the American Academy of Sleep Medicine (AASM) for patients with 
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insomnia and related sleep problems (Morgenthaler, Kramer, Alessi, Boehlecke, & Brown, 2006; 
Qaseem et al., 2016).  CBT-I is a multicomponent treatment that addresses the perpetuating 
mechanisms implicated in the development and maintenance of insomnia (Williams et al., 2013).  
Specifically, CBT-I targets the behaviors, cognitions, and beliefs that negatively impact sleep 
(Perlis, Jungquist, Smith, & Posner, 2006; Riemann & Perlis, 2009).  CBT-I treatment 
components are detailed in Table 3.  
Table 3. CBT-I Treatment Components 
 Description 
Stimulus Control 
Behavioral intervention to strengthen association between bed and sleep and 
undermine conditioned response of wakefulness in bed 
Sleep Hygiene 
Guidelines for developing healthy habits to promote sleep, such as eliminating 
caffeine later in the day, reducing alcohol consumption, developing a relaxing 
bedtime routine, and creating a positive sleep environment 
Sleep Restriction 
Behavioral intervention aimed at increasing sleep drive and improving sleep 
efficiency (SE) by reducing time in bed to match the patient’s current perceived 
TST and adjusting over time to achieve >85% SE 
Relaxation 
Training 
Techniques to promote relaxation, reduce cognitive arousal, and ease muscle 
tension to facilitate sleep 
Cognitive 
Restructuring 
Cognitive intervention aimed at identifying, challenging, and replacing 
dysfunctional beliefs and attitudes about sleep, such as unrealistic sleep 
expectations, overestimated consequences of disturbed sleep, and fear of sleep 
loss 
 
Despite substantial evidence (see meta-analysis by Trauer et al., 2015) and guidelines 
recommending CBT-I (e.g., AASM, American College of Physicians, Agency for Healthcare 
Research and Quality), it is rarely implemented outside of specialty sleep medicine practices 
(Edinger & Sampson, 2003; Espie MacMahon, Kelly, Broomfield, Douglas, Engleman et al., 
2007).  Often, CBT-I is unavailable due to geographic restrictions limiting access to trained 
providers.  Many patients are also ambivalent about seeking specialty sleep medicine services 
which may be burdensome to them due to the time commitment (CBT-I requires ~4-8 sessions), 
insurance co-payments, out of pocket fees, and lost wages.  Despite empirical support and 
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endorsement for the widespread use of CBT-I, limitations in healthcare workforce training 
restrict access to treatment and for those who do have access to behavioral sleep medicine 
specialists trained in CBT-I, treatment duration and cost can be barriers. 
Given these limitations, it is not surprising that pharmacological intervention is the most 
common first-line treatment used in clinical practice.  Prescription sleep aids are widely used in 
primary care (van der Zweerde et al., 2016; Edinger & Sampson, 2003), with benzodiazepines 
(e.g., flurazepam, temazepam) and non-benzodiazepine receptor agonists (e.g., zolpidem, 
eszopiclone, zaleplon) being prescribed most frequently (Hoebert, Souverein, Mantel-Teeuwisse, 
Leufkens, & van Dijk, 2012).  Approximately 60% of primary care patients with insomnia 
symptoms are prescribed benzodiazepine-related medication (van der Zweerde et al., 2016).     
Consequences of these medications are notable, including unwanted side effects (e.g., 
headaches, dizziness, daytime fatigue), rebound insomnia, and high potential for abuse and 
dependence (Qaseem, Kansagara, Forciea, Cooke, & Denberg, 2016; Pigeon, Bishop, & Marcus, 
2014).  Though pharmacological treatment can be effective for short-term sleep management, it 
is not supported for long-term treatment (Qaseem et al., 2016).  Similarly, over-the-counter 
(OTC) sleep aids (e.g., diphenhydramine) provide short-term relief due to their sedating effects 
(Pigeon, Bishop, & Marcus, 2014).  However, patients tend to habituate rapidly and may develop 
a tolerance within as few as 4 days (Pigeon, Bishop, & Marcus, 2014); therefore, OTC sleep aids 
are not indicated for long-term management of sleep problems either.  Moreover, prescription 
and OTC sleep aids are often contraindicated for patients with multiple morbidities, cardiac or 
respiratory illness, cognitive impairment, and for older adults (Williams et al., 2013).  Given the 
current limitations of both medication sleep aids and non-pharmacological treatments, 
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researchers have continued to explore alternative modalities and mechanisms to target in sleep 
treatment. 
Sleep Misperception 
Sleep misperception, also known as sleep discrepancy, has been identified as a potential 
treatment target.  Sleep misperception – discrepancy between subjective reports and objective 
measures (e.g., polysomnography, actigraphy) of sleep disturbance – is a widely observed 
phenomenon among problem sleepers and insomniacs (Moon, Song, & Cho, 2015; Harvey & 
Tang, 2012; Means, Edinger, Glenn, & Fins, 2003).  Extreme sleep discrepancy constitutes an 
insomnia subtype known as paradoxical insomnia (AASM, 2014; WHO, 1992).  Paradoxical 
insomnia (also known as sleep state misperception or subjective insomnia), involves a subjective 
complaint of insomnia symptoms without objective evidence of short duration sleep (AASM, 
2014).  Specifically, paradoxical insomnia requires total sleep time greater than 6.5 hours as 
measured by polysomnography (PSG), 85% sleep efficiency (ratio of total sleep time to time in 
bed), and less impairment in daytime functioning than would be expected given the severity of 
subjective sleep complaints (Research Diagnostic Criteria; Edinger et al., 2004).  Patients with 
paradoxical insomnia often misperceive sleep duration and sleep onset latency, significantly 
underestimating the total amount of time they are asleep and overestimating the amount of time 
it takes them to fall asleep (Vanable, Aikens, Tadimeti, Caruana-Montaldo, & Mendelson, 2000; 
Tang & Harvey, 2004, 2006; Van den Berg et al., 2008).  Despite self-reports of severe sleep 
deficits, these individuals do not exhibit daytime sleepiness that would be expected to 
accompany sleep insufficiency (Rezaie, Fobian, McCall, & Khazaie, 2018).  In contrast to 
paradoxical insomnia, psychophysiologic insomnia (also known as objective insomnia) is a 
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subtype diagnosed in patients who have objective evidence of insufficient sleep (<6.5 hours) 
congruent with self-reported sleep deficits (AASM, 2014).   
Sleep Misperception: Patient Characteristics 
A key distinction between these two subtypes is the degree of patient accuracy in self-
reported sleep compared to objective measures of sleep.  Those with psychophysiologic 
insomnia have more accurate perceptions about their sleep, whereas those with paradoxical type 
exhibit greater sleep discrepancy, overestimating the degree of sleep impairment.  Moreover, 
individuals who accurately perceive true sleep deficits (psychophysiologic type) are more likely 
to have personality profiles consistent with those seen in medical patient populations and have 
comorbid medical problems (Fernandez-Mendoza, Calhoun, Bixler, Karataraki, Liao, Vela-
Bueno, Ramos-Platon, et al., 2011; Vgontzas et al., 2013).   
In contrast, those who overestimate their sleep impairment (paradoxical type) are more 
likely than accurate perceivers to exhibit elevations in the domains of depression and anxiety 
(Fernandez-Mendoza et al., 2011).  Similarly, patients with both insomnia and depression have 
been found to be more likely to exhibit greater sleep discrepancy (Bliwise, Friedman, & 
Yesavage, 1993; Edinger & Fins, 1995).  It has been suggested that this observed relationship 
may be the result of increased psychological distress associated with the perception that one is 
not receiving adequate sleep (Harvey & Tang, 2012).  Research has found a direct relationship 
between anxiety and sleep misperception, such that individuals with higher levels of worry have 
been observed to exhibit greater sleep discrepancy (Harvey, 2005).   
Identifying the extent to which patients who report sleep difficulties also have sleep 
misperceptions and associated clinical characteristics may be important to inform clinical 
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decision-making.  Vgontzas and colleagues (2013) suggest that patients who accurately perceive 
true sleep deficiencies may respond better to biological interventions; therefore, these patients 
may directly benefit from immediate initiation of pharmacological treatment to address short 
duration sleep.  In contrast, patients overestimate sleep impairment may benefit from 
interventions that address cognitive, behavioral, or psychological factors before initiating 
pharmacological treatment (Moon, Song, & Cho, 2015; Vgontzas et al., 2013). 
While sleep misperception is prevalent among problem sleepers, this phenomenon is not 
observed among those with good sleep (Manconi et al., 2010).  For those who do evidence sleep 
misperception, the degree of discrepancy between self-report and objectively measured sleep 
varies widely and most do not meet criteria for paradoxical insomnia (Edinger & Fins, 1995; 
Harvey & Tang, 2012).  Given the ubiquity of sleep misperception among problem sleepers, its’ 
relative absence among good sleepers, and the variability of discrepancy among misperceivers, it 
has been suggested that misperception may be better characterized as dimensional, rather than 
categorical (Fernandez-Mendoza et al., 2012; Vgontzas, Fernandez-Mendoza, Liao, & Bixler, 
2013).  Within this framework, paradoxical insomnia would represent the extreme end of the 
misperception continuum (Fernandez-Mendoza et al., 2012; Vgontzas, Fernandez-Mendoza, 
Liao, & Bixler, 2013).   
Even in the presence of sleep misperception, patients may experience insufficient sleep.  
Thus, sleep discrepancy should not be taken as an indication that no sleep disturbance exists but 
rather may indicate that an individual perceives her/his sleep to be impaired above and beyond 
the true sleep deficit.  For instance, a patient with sleep complaints may report sleeping three 
hours per night on average, whereas objective testing may reveal that the patient is sleeping five 
hours per night.  Despite the inaccuracy of the patient’s subjective report, he/she is clearly still 
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experiencing a sleep deficit.  In contrast, many sleep under-estimators do achieve sufficient sleep 
(Harvey & Tang, 2012).  This group may be at elevated risk for developing true sleep deficits, 
due to increased anxiety and worry about sleep, associated distress, and heightened vigilance and 
arousal that may impair actual sleep (Harvey, 2002; Harvey & Tang, 2012). 
Correcting Sleep Misperceptions 
Research has explored the possibility of reversing or correcting sleep misperceptions as a 
means of improving sleep.  In one lab-based polysomnographic study, researchers corrected 
misperceptions among participants with paradoxical insomnia by training them to differentiate 
sleep from wake during various sleep stages (Downey & Bonnet, 1992).  Following the training, 
participants were better able to discriminate between sleep and wake and reduced sleep onset 
latency (Downey & Bonnet, 1992).  Mercer, Lack, and Bootzin (2005) expanded this line of 
research using immediate and retrospective feedback during wake periods and following 
scheduled awakenings during various sleep stages.  Both forms of feedback reduced sleep 
misperception and improved sleep in paradoxical insomniacs (Mercer, Lack, & Bootzin, 2005).   
These previous studies were limited by small sample sizes and reliance on expensive 
equipment (i.e., polysomnography) and specialized technicians.  Tang and Harvey (2004) 
addressed these limitations in their study, which evaluated a behavioral intervention to correct 
sleep misperceptions using wrist actigraphy.  The behavioral intervention consisted of an 
instruction period in which participants learned to interpret their own actigraphic sleep data 
(Tang & Harvey, 2004).  Three days post-intervention, those who received the behavioral 
intervention reported more accurate sleep perceptions (total sleep time, sleep onset latency), 
improved subjective sleep quality (PSQI), and less sleep-related anxiety and preoccupation 
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compared to control participants (Tang & Harvey, 2004).  Tang and Harvey (2006) extended this 
research to include an additional comparison group who received a verbal feedback-only 
intervention, without the behavioral or visual components.  Similar to the original study, 
improvements in self-reported sleep, insomnia symptoms, and sleep-related anxiety and distress 
were observed for both intervention conditions, though larger effects were found in the 
behavioral intervention group compared to the verbal feedback-only group (Tang & Harvey, 
2006).  Results of this study were consistent with previous findings that brief corrective feedback 
can be effective in reducing sleep discrepancy and improving self-reported sleep.  Further, these 
results support corrective feedback as a method for reducing cognitive distortions related to 
sleep, thereby addressing a characteristic factor known to perpetuate sleep problems (Harvey, 
2002). 
Quintiliani and colleagues (2017) expanded on Harvey and Tang’s work to examine a 
single-session psychoeducational sleep intervention with medical patients diagnosed with 
chronic insomnia.  In this study, sleep data were collected using wrist actigraphs and sleep 
diaries for a total of two weeks.  After one week of recording, participants in the treatment group 
received a brief feedback intervention during which trained clinicians reviewed actigraphic and 
sleep diary results with each individual, emphasizing any sleep discrepancies.  Sleep data were 
collected from the control group after one week as well but no intervention was provided.  All 
participants then completed a second week of recording before returning to the clinic to complete 
final assessment measures.  Consistent with previous studies, improvements in sleep 
misperception, sleep-related psychological distress, and subjective sleep quality were observed in 
the treatment group (Quintiliani et al., 2017).     
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Summary and Study Aims 
Preliminary research supports brief corrective feedback interventions to improve sleep 
perceptions.  Findings to date suggest that brief corrective feedback can be effective in 
decreasing sleep discrepancy, improving self-reported sleep quality and quantity, and reducing 
sleep-related distress (Downey & Bonnet, 1992; Mercer, Lack, & Bootzin, 2005; Quintiliani et 
al., 2017; Tang & Harvey, 2004, 2006).  Although such interventions show promise, research has 
been conducted only with samples meeting diagnostic criteria for insomnia.  Further research is 
needed to allow for greater generalizability to populations other than those with diagnosed 
insomnia.  Specifically, research is needed with problem sleepers more broadly, given the 
commonality of sleep misperception among this group as well as the potential preventive effects 
of corrective feedback.  To date, studies have also used expensive equipment (i.e., PSG, 
research-grade actigraphs) for objective sleep measurement.  Such equipment is not practical for 
routine clinical use, therefore, research using more economical measures is needed to expand the 
ecological validity of these findings to clinical practice.   
The present study aimed to extend previous work by investigating, in an outpatient 
medical setting, the prevalence of sleep misperception among a diverse sample of self-identified 
problem sleepers using a commercially available actigraph (Fitbit Charge HR™).  Specific study 
aims were to: 
1) Determine if sleep misperception is present in a sample of self-identified problem 
sleepers for total sleep time (TST) and sleep onset latency (SOL). 
a. Hypothesis: Discrepancies will be observed between sleep diary and Fitbit-
measures for TST and SOL. 
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2) Determine if psychological and medical factors are associated with sleep 
misperception (i.e., TST and SOL). 
a. Hypothesis: Patients with worse medical health (SF-36 Mental Health 
Composite) will have more accurate sleep perceptions (smaller discrepancies). 
b. Hypothesis: Patients with higher anxiety and depression (GAD-7, PHQ-9) will 
have less accurate sleep perceptions (greater discrepancies). 
3) Examine the impact of a single-session feedback intervention in correcting sleep 
discrepancies. 
a. Hypothesis: Discrepancies between sleep diary and Fitbit-measured sleep 
(TST, SOL) will be reduced from baseline to follow-up. 
b. Auxiliary hypotheses: Reductions will be observed from baseline to follow-up 
for self-reported sleep variables (ISI, sleep diary TST and SOL), medical 
functioning (SF-36 Physical Health Composite), and psychological 






Participants and recruitment 
The study was conducted at UCF Health outpatient medical practice.  Patients were 
recruited as a part of standard clinical practice and within the workflow of medical providers at 
UCF Health as well as through printed recruitment flyers placed in the waiting area and exam 
rooms and on the UCF Health website.  It is well established that sleep problems are often 
comorbid with other medical and mental health conditions and patients rarely present with sleep 
problems in isolation; therefore, to maximize the clinical relevance and ecological validity of this 
study, broad inclusion criteria were used.  Patients were invited to participate in the study if they 
were 18 years or older, endorsed subjective sleep problems, and were interested in receiving a 
non-pharmacological feedback intervention for sleep.  Sleep data were collected using the Fitbit 
Charge HR™, thus, to be eligible patients had to be willing and able to wear the Fitbit on their 
non-dominant wrist.  Patients with severe psychological conditions (e.g., suicidality, psychosis), 
acute substance use or dependence, and those with diagnosed obstructive sleep apnea who were 
not compliant with medical treatment (i.e., use of CPAP) were not eligible for the study.  As 
pregnant women face a unique set of risk factors they were not eligible for the study.  Children 
and incarcerated individuals also were not eligible for the study.  Participant recruitment began 
upon IRB approval in September 2016.  All participants were asked to attend three visits at UCF 
Health, as detailed below.  Enrollment for this study was continuous. 
Study design and procedures 
Visit 1 (Baseline): Individual assessments were conducted in the patient consultation 
rooms at UCF Health.  Each participant met individually with the PI to complete consent 
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procedures and complete a questionnaire battery consisting of the following measures: Insomnia 
Severity Index, Dysfunctional Beliefs and Attitudes about Sleep Scale-16, Epworth Sleepiness 
Scale, Pittsburgh Sleep Quality Index, Short Form-36, Generalized Anxiety Disorder-7, Patient 
Health Questionnaire-9, and the Alcohol Use Disorders Identification Test (described below and 
in Appendices).  Information obtained from participant electronic medical records was reviewed 
with participants for accuracy (specifically: age, weight, medication list, diagnoses and problem 
list).  Participants then completed an individual sleep assessment with the PI lasting 
approximately 45 minutes and were fitted with the Fitbit Charge HR™, provided with a sleep 
diary, and instructed in their use.  The instruction period lasted about 15 minutes.     
Patients were asked to wear the Fitbit and complete a sleep diary for seven days.  
Participants returned to UCF Health approximately one week after the initial visit to complete 
the intervention portion of the study. 
Visit 2 (Feedback Intervention): Patients returned after recording sleep for one week and 
patient sleep data (sleep diary and Fitbit) were reviewed for misperceptions.  Each patient 
completed the Short Form-36 questionnaire (measure of global health and quality of life) at the 
beginning of the feedback session.  The intervention consisted of a single session lasting 
approximately 30 minutes, during which the participant was provided with written and verbal 
feedback about their sleep (see Appendix for sample).  The feedback report was based on data 
derived from sleep diaries and actigraphic sleep data from the Fitbit Charge HR™, extracted 
from Fitabase™, a web-based research platform.  All participants received the intervention.  
After receiving the feedback intervention, participants were asked to wear the Fitbit and 
complete the daily sleep diary for an additional week. 
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Visit 3 (Follow-Up): Approximately one week after the feedback session, participants 
returned to UCF Health to meet with a study clinician, at which time they returned their 
completed sleep diary and Fitbit device.  Participants were asked to complete the initial 
questionnaire battery again, along with a measure of patient satisfaction (see Appendix J).  
Participation in the study was then complete.  Patients were provided contact information for the 
behavioral health team and were offered the opportunity to initiate services if desired. 
Measures 
Insomnia Severity Index (ISI; Morin et al., 2003).  The ISI is a 7-item self-report 
inventory designed to assess the severity of common symptoms of insomnia over the past two 
weeks.  Items are presented on a Likert scale and individual items range from 0 (none) to 4 (very 
severe) and scores are summed to provide a total score ranging from 0 to 28.  Scores are 
categorized based on the following cutoffs: 0-7 = no clinically significant insomnia; 8-14 = 
subthreshold insomnia; 15-21 = clinical insomnia (moderate severity); 22-28 = clinical insomnia 
(severe).  The ISI has been shown to detect clinically meaningful treatment response (Morin et 
al., 2011).  Cronbach’s alpha in the present sample was 0.74 at baseline and 0.70 at follow-up.  
See Appendix A. 
Dysfunctional Beliefs and Attitudes about Sleep Scale – 16 (DBAS-16; Morin, 
Vallieres, & Ivers, 2007). The DBAS-16 is a 16-item questionnaire used to assess sleep-
disrupting cognitions and beliefs. This measure provides an overall score with higher scores 
indicating higher levels of dysfunctional beliefs about sleep.  Scores are calculated as the mean 
of all item responses and scores greater than four, or any single item response of 6 or more 
indicates unrealistic expectations or beliefs about sleep or one’s ability to cope with poor sleep.  
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Cronbach’s alpha in the present sample was 0.79 at baseline and 0.88 at follow-up.  See 
Appendix B. 
Epworth Sleepiness Scale (ESS). The ESS is an 8-item self-report measure used to 
assess daytime sleepiness.  This measure produces a total score ranging from 0 to 24 with 
validated cutoffs.  A total score of 10 or more or a score of 3 on any item indicates clinically 
significant symptoms in need of further evaluation.  Cronbach’s alpha in the present sample was 
0.83 at baseline and 0.77 at follow-up.  See Appendix C. 
Short Form-36: Acute (SF-36; Maruish, 1993, 2011). The SF-36 is a 36-item inventory 
that measures quality of life across eight domains (physical functioning, bodily pain, role 
limitations due to physical health problems, role limitations due to personal or emotional 
problems, emotional well-being, social functioning, energy/fatigue, and general health 
perceptions).  This measure is validated and widely used in medical research.  Physical 
Component Summary and Mental Component Summary scores were derived from this measure.    
Scores falling between 45 and 55 are considered to be in the average range of functioning.  
Higher scores indicate better functioning.  See Appendix D. 
Patient Health Questionnaire-9 (PHQ-9; Kroenke, Spitzer, & Williams, 2001).  The 
PHQ-9 is a 9-item self-report inventory used to assess the severity of common symptoms of 
depression over the past two weeks.  Items are presented on a Likert scale with item responses 
from 0 = Not at all to 3 = Nearly every day.  Total scores range from 0 to 27 with the following 
cutoffs: 5-9 = mild; 10-14 = moderate; 15-19 = moderately severe; ≥20 = severe.  The PHQ-9 
has been validated for use in medical settings.  Cronbach’s alpha in the present sample was 0.80 
at baseline and 0.81 at follow-up.  See Appendix E. 
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Generalized Anxiety Disorder-7 (GAD-7; Kroenke, Spitzer, Williams, Monahan, & 
Lowe, 2007; Kroenke, Williams, & Lowe, 2006).  The GAD-7 is 7-item self-report inventory 
designed to assess for the presence and severity of common symptoms of anxiety over the past 
two weeks.  Items are presented on a Likert scale with item responses from 0 = Not at all to 3 = 
Nearly every day.  Total scores range from 0 to 21 with the following cutoffs: 5-9 = mild; 10-14 
= moderate; ≥15 = severe.  This measure is validated for use in medical settings (Kroenke et al., 
2007).  Cronbach’s alpha in the present sample was 0.86 at baseline and 0.87 at follow-up.  See 
Appendix F. 
Alcohol Use Disorders Identification Test (AUDIT; Babor, de la Fuente, Saunders, & 
Grant, 1992; Saunders, Aasland, Babor, de la Fuente, & Grant, 1993).  The AUDIT is a brief 
screening tool that is commonly used to assess patients’ alcohol use.  This measure provides a 
total score with the following cutoffs for alcohol use risk level: 0-7 = low risk; 8-15 = moderate 
risk of harm; 16-19 = high risk; ≥20 = likely dependence.  Cronbach’s alpha in the present 
sample was 0.85 at baseline and 0.88 at follow-up.  See Appendix G. 
Sleep Outcomes.  Sleep outcomes were derived from sleep diaries and a consumer-grade 
activity monitor (Fitbit Charge HR™).  Data collected from the sleep diary and Fitbit were used 
to calculate subjective and objective sleep outcomes, respectively.  Sleep outcomes were 
calculated as: 
Total sleep time (TST): total time (in minutes) between sleep initiation and final 
awakening minus WASO (wake after sleep onset). 
Sleep onset latency (SOL): amount of time (in minutes) between “lights out” and sleep. 
Misperception Index (MI): To assess TST misperception, a Misperception Index (MI; 
Manconi et al., 2010) was calculated using the following formula.  This formula has 
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been suggested as a useful method for quantifying patient accuracy for total sleep time 
(Buysse et al., 2006).  
MI = [(TSTFitbit – TSTDiary)/TSTFitbit] 
Negative index scores indicate TST overestimation and positive scores indicate 
underestimation.  Plainly stated, patients with positive scores are sleeping more than 
they think and patients with negative scores are sleeping less than they think.  Scores are 
presented on a scale from -1.0 to +1.0.  Though it is feasible that negative scores could 
be infinite if a patient were to overestimate TST to such a degree.  However, such a 
report is very unlikely and would represent an extreme outlier.  Therefore, consistent 
with previous research (Manconi et al., 2010), overestimation scores are truncated at -
1.0 for practicality and ease of interpretation.   
Sleep diaries are the most widely used measure of sleep functioning and provide a 
subjective report of sleep.  The Consensus Sleep Diary (CSD-E; Carney et al., 2012) was used in 
this study (See Appendix H).  Patients were provided written instructions for completing the 
diary according.  Questions about sleep-interfering behaviors (e.g., prescription/OTC sleep 
medication use, caffeine and alcohol consumption) were answered at night, whereas questions 
about actual sleep (e.g., awakenings, final wake time) and perceived quality of sleep were 
completed in the morning. 
The Fitbit Charge HR™ (Fitbit Inc., San Francisco, CA, USA) was used to monitor sleep 
as an objective measure of sleep.  This Fitbit model has been established in recent research (de 
Zambotti et al., 2016).  Further, the Fitbit offers an attractive alternative to the gold standards of 
PSG and research-grade actigraphy, due to its’ lower cost, availability, and widespread consumer 
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use.  The device uses tri-axial accelerometer technology to measure gross motor activity 
continuously while worn.  Patients were asked to wear the device on their non-dominant wrist.  
The data were synced to a web-based research platform (Fitabase™), downloaded to a computer, 
and analyzed using computer generated algorithms. 
Statistical analyses 
All data were analyzed using IBM SPSS Version 24.0 (IBM Corp., 2016).  Skewness and 
kurtosis values were calculated for all outcome and predictor variables to assess for normality 
and all fell within the accepted range (George & Mallery, 2010).  Paired samples t-tests were 
used to evaluate sleep discrepancies between Fitbit and sleep diary measures.  Linear regression 
analyses were conducted to examine associations between sleep discrepancy variables and 
mental and physical health predictor variables.  Separate analyses were completed for TST and 
SOL.  Paired samples t-tests were performed to assess change in sleep and self-report measures 
from baseline to follow-up (i.e., one-week post-intervention).  Cohen’s d was calculated to 
evaluate the magnitude of intervention effects for all pre-post t-test analyses.  The following 
cutoffs were used to categorize Cohen’s d effect sizes (ES): d = 0.20–0.49 (small); d = 0.50–0.79 
(medium); d  0.80 (large).  In keeping with the guidelines set out by the National Register for 
actigraphic sleep assessment, participants were required to have a minimum of three days of 
usable sleep data in order to be included in any analysis of that particular sleep outcome.  Those 






Forty-five participants between the ages of 20 and 79 were enrolled in the study.  One 
participant withdrew less than one week after enrolling due to extenuating personal 
circumstances (i.e., family emergency requiring extended travel out of the country) and was 
excluded from all analyses.  The majority of participants were female (n=27, 60%), identified as 
heterosexual (n=44, 98%), and were married (n=25, 56%).  Though only 22% of participants had 
been previously diagnosed with insomnia, most met diagnostic criteria for either chronic or acute 
insomnia (n=43, 95%) at baseline.  Seventy-three percent of participants reported at least a 
moderate level of insomnia symptoms (ISI  15) at baseline.  Thirty-three percent endorsed 
moderate or severe depression symptoms (PHQ-9  10) and 31% endorsed moderate or severe 
anxiety symptoms (GAD-7  10).  Demographic and baseline characteristics are provided in 
Tables 4 and 5. 
Table 4. Participant demographics 
Variable M SD 
Age, years 52.71 17.10 
Sex, n (%)   
Female 27 (60%) -  
Male 18 (40%) -  
Race, n (%)   
Caucasian 30 (66.7%) -  
Hispanic 9 (20.0%) -  
African American 5 (11.1%) -  
Other 1 (2.2%) -  
Sexual Orientation, n (%)   
Heterosexual 44 (97.8%) -  
Homosexual 1 (2.2%) -  
Relationship Status, n (%)   
Single, never married 5 (11.1%) -  
In a committed relationship 5 (11.1%) -  
Married 25 (55.6%) -  
Divorced 4 (8.9%) -  
Widowed 6 (13.3%) -  
Employment Status, n (%)   
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Variable M SD 
Employed 22 (48.9%) -  
Unemployed 6 (13.3%) -  
Retired 12 (26.7%) -  
Disabled 3 (6.7%) -  
Student 2 (4.4%) -  
Education, n (%)   
Graduate degree 11 (24.4%) -  
College degree, 4-year 15 (33.3%) -  
College degree, 2-year 7 (15.6%) -  
Some college 8 (17.8%) -  
High school diploma 3 (6.7%) -  
Other 1 (2.2%) -  
 
Table 5. Participant characteristics at baseline 
Variable M SD 
Sleep related diagnosis, n (%)^   
Insomnia 10 (22.2%) - 
Obstructive Sleep Apnea 4 (8.9%) - 
Restless Leg Syndrome 1 (2.2%) - 
“Sleep difficulties” 4 (8.9%) - 
Meet diagnostic criteria for Insomnia, n (%) 43 (95.6%) - 
Chronic 39 (86.7%) - 
Acute 4 (8.9%) - 
Sleep medication use, n (%)^   
Prescription 15 (33.3%) - 
OTC 4 (8.9%) - 
Melatonin 9 (20.0%) - 
BMI^ 29.23 6.77 
^per medical record. BMI = Body mass index; OTC = over the counter. 
Sleep discrepancy analyses 
Mean discrepancies between Fitbit and sleep diary measures are displayed in Table 6.  
Across outcomes and time points, sleep diary reports overestimated sleep impairment compared 
to Fitbit measurement.  For total sleep time (TST), Fitbit measurements were higher on average 
by 52.94 minutes at baseline and 24.20 minutes at one-week follow-up, compared to sleep diary 
estimates.  For sleep onset latency (SOL), Fitbit measurements were lower on average by 24.99 
minutes at baseline and 14.41 minutes at one-week follow-up.  Consistent with hypotheses, sleep 
misperceptions were observed such that participants underestimated their total amount of sleep 
per night and overestimated the amount of time it takes them to fall asleep.  See Figures 1 and 2. 
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Table 6. Sleep discrepancies at baseline and one-week follow-up 
Sleep Feature N Fitbit M (SD) Sleep diary M (SD) Mean diff (SE) t 
TST, baseline 38 438.34 (66.52) 385.40 (73.74) 52.94 (11.09) 4.78* 
TST, follow-up 37 434.97 (61.35) 410.77 (53.63) 24.20 (5.62) 4.31* 
SOL, baseline 35 11.67 (10.09) 36.66 (30.23) -24.99 (4.60) -5.43^ 
SOL, follow-up 35 10.47 (10.21) 24.88 (19.48) -14.41 (2.71) -5.31* 




Figure 1. Baseline TST discrepancy 
 





Depression scores significantly predicted SOL discrepancy, b = -.37, t(39) = -2.46, p = 
.018 but not TST discrepancy.  Physical health scores were not a significant predictor of sleep 
discrepancy for SOL or TST.  Anxiety scores were not a significant predictor of TST 
discrepancy or SOL discrepancy.  Unstandardized coefficients, standard errors, and t-values are 
displayed in Tables 7 and 8. 
Table 7. Unstandardized regression coefficients for predictors of TST Misperception Index 
Predictor variable N B SE B t p 
Physical health (PCS) 43 .001 .002 .54 .593 
Depression (PHQ-9) 43 .001 .005 .27 .789 
Anxiety (GAD-7) 43 -.009 .005 -2.01 .051 
PCS = Physical Composite Scale of the Short-Form-36; PHQ-9 = Patient Health Questionnaire; 
GAD-7 = Generalized Anxiety Disorder 7-item scale. 
 
Table 8. Unstandardized regression coefficients for predictors of SOL discrepancy 
Predictor variable N B SE B t p 
Physical health (PCS) 40 .30 .50 .59 .558 
Depression (PHQ-9) 40 -2.37 .96 -2.46 .018 
Anxiety (GAD-7) 40 -1.26 1.03 -1.22 .228 
PCS = Physical Composite Scale of the Short-Form-36; PHQ-9 = Patient Health Questionnaire; 
GAD-7 = Generalized Anxiety Disorder 7-item scale. 
Intervention effects 
Paired samples t-tests were conducted to evaluate changes pre- to post-treatment.  
Significant improvements were observed for sleep diary measures of TST and SOL and for TST 
discrepancy.  Self-reported TST increased on average by 19.69 minutes per night from baseline 
to one-week follow-up.  Self-reported SOL decreased from baseline, with participants reporting 
an average SOL of less than 30 minutes at follow-up.  TST discrepancy decreased on average by 
31.16 minutes from baseline to follow-up.  No significant differences were observed in SOL 
discrepancy or in Fitbit measures of TST or SOL from baseline to follow-up.  Means, standard 
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deviations, t-values, and effect sizes with 95% confidence intervals are displayed in Table 9. 
Table 9. Differences in sleep features from baseline to follow-up 
Sleep Feature N Baseline M (SD) Follow-up M (SD) t d (95% CI) 
Fitbit Charge HR™      
TST, mean 41 441.88 (65.52) 443.34 (66.39) -.24 0.04 (-0.40, 0.47) 
SOL, mean 42 13.66 (19.01) 10.38 (9.92) 1.36 -0.19 (-0.62, 0.24) 
Sleep diary      
TST, mean 41 392.39 (78.69) 412.08 (53.14) -2.11^ 0.30 (-0.14, 0.73) 
SOL, mean 40 39.57 (32.75) 28.32 (26.61) 4.26* -0.65* (-1.10, -0.20) 
Sleep discrepancy      
TST disc, mean 38 52.34 (68.28) 21.18 (32.51) 3.94* -0.65* (-1.11, -0.19) 
TST MI, mean 38 .11 (.15) .04 (.08) 4.23* -0.64* (-1.10, -0.18) 
SOL disc, mean 37 -24.30 (32.38) -17.25 (28.38) -1.91 0.30 (-0.16, 0.76) 
*p<.001; ^p<.05. TST = total sleep time; SOL = sleep onset latency; MI = misperception index; 
disc = discrepancy between Fitbit and sleep diary. TST and SOL are reported in minutes. 
Follow-up was conducted one-week post-intervention. 
 
 





Figure 4. Sleep Diary Mean TST Pre-Post Intervention 
 
 




Figure 6. Sleep Diary Mean SOL Pre-Post Intervention 
 
Paired-samples t-tests also revealed significant reductions in insomnia (ISI), depression 
(PHQ-9), and anxiety (GAD-7) symptoms from baseline to one-week follow-up.  Insomnia 
symptom severity decreased from moderately severe to subthreshold insomnia.  Depression and 
anxiety scores remained in the mild range but evidenced statistically significant improvements 
from baseline to follow-up.  Mental health scores (SF-36, MCS) improved significantly, falling 
within the average range of functioning at follow-up.  No significant differences were observed 
in sleep beliefs (DBAS), daytime sleepiness (ESS), or physical health functioning (SF-36, PCS) 
from baseline to follow-up.  Means, standard deviations, t-values, and effect sizes with 95% 




Table 10. Differences in self-report measures from baseline to follow-up 
Questionnaire N Baseline Follow-up t d (95% CI) 
Insomnia Severity Index 44 17.14 (4.15) 14.00 (4.22) 6.68* -1.02 (-1.46, -0.57) 
Sleep beliefs (DBAS) 43 6.06 (1.56) 5.79 (1.71) 1.58 -0.26 (-0.69, 0.16) 
Epworth Sleepiness Scale 44 8.86 (5.11) 8.23 (4.68) 1.43 -0.21 (-0.63, 0.21) 
Short Form-36      
Physical health composite (PCS) 43 47.29 (10.29) 46.82 (10.46) .65 -0.10 (-0.52, 0.32) 
Mental health composite (MCS) 43 41.62 (11.30) 47.93 (9.28) -6.48* 0.94 (0.50, 1.39) 
Depression symptoms (PHQ-9) 44 8.59 (4.78) 7.23 (4.87) 3.17^ -0.48 (-0.91, -0.06) 
Anxiety symptoms (GAD-7) 44 7.18 (4.75) 5.61 (4.95) 2.53^ -0.39 (-0.81, 0.03) 
*p<.001; ^p<.05; d = repeated measures using baseline SD. DBAS = Dysfunctional Beliefs and 
Attitudes about Sleep scale; PHQ-9 = Patient Health Questionnaire; GAD-7 = Generalized 
Anxiety Disorder 7-item scale. 
 
 





Figure 8. Mental Composite Score (SF-36) Pre-Post Intervention 
 





Figure 10. Depression scores (PHQ-9) Pre-Post Intervention 
 
Figure 11. Anxiety scores (GAD-7) Pre-Post Intervention 
 
Patient Perceptions of Intervention 
Descriptive statistics were examined for the patient perceptions measure completed at 
follow-up.  Overall, participants reported positive responses and perceptions of the feedback 
intervention.  All participants indicated that the feedback was useful and informative and that 
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they had a better understanding of their own sleep patterns after receiving the intervention.  
Eighty percent of participants believed the Fitbit accurately measured their sleep and all 
participants found the device easy to use.  Sixty-five percent reported that they intend to 
purchase a Fitbit or other sleep monitoring device after completing the study.  Lastly, all 
participants would recommend this study to others and a most (91%) endorsed interest in having 
consumer technology incorporated into routine clinical care.  See Figures 12-19. 
 




















Figure 13. Perception of feedback as informative 
 
 




































Figure 15. Perception of Fitbit as accurate 
 
 






























The Fitbit Charge HR™ was easy to use. 




Figure 17. Plan to purchase a Fitbit 
 
 















I plan to purchase a Fitbit™ or another sleep monitoring device after 
participating in this study. 



































I would like for my physician to use consumer technology products (e.g., 





Results of the present study are consistent with previous findings, showing that sleep 
misperception is prevalent among problem sleepers and that sleep discrepancy can be reduced 
through the use of corrective sleep feedback.  This study expands on previous research to 
examine sleep misperception in a diverse outpatient medical sample of self-identified problem 
sleepers, using consumer-grade wearable actigraphs. 
Similar to previous studies (Morin & Benca, 2012; Quintilliani et al., 2017), objectively 
measured TST and SOL remained relatively unchanged from baseline to follow-up.  Despite this 
lack of change in actual sleep, participants perceived themselves to be sleeping more hours per 
night, falling asleep more quickly, and sleeping better overall at one-week follow-up.  Perceived 
sleep impairment has been shown to cause sleep-related anxiety and distress and can result in 
objective sleep impairment, even among those without true impairment previously (Harvey & 
Tang, 2012; Mercer, Bootzin, & Lack, 2002).  In the present study, nearly 70% of participants 
were sleeping the recommended minimum of seven hours per night on average at baseline, 
whereas only 31% believed they were sleeping at least seven hours.  This population of 
misperceivers may be at risk for developing objective sleep impairment.  This finding has 
important clinical implications.  Given the malleability of sleep misperception, it is feasible that 
corrective sleep feedback could disrupt the cycle of insomnia by reducing sleep discrepancy and 
subsequently reducing sleep-related anxiety and distress (Quintiliani et al., 2017; Semler & 
Harvey, 2005). 
The present study also sought to explore predictors of sleep misperception.  As 
hypothesized, depression was found to predict SOL discrepancy, such that those with elevated 
depression scores were more likely to report larger overestimations of SOL.  However, contrary 
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to previous research (Fernandez-Mendoza et al., 2011; Vgontzas et al., 2013), TST 
misperception was not associated with elevations in depression or anxiety nor did poor physical 
health predict lower levels of sleep discrepancy in the present study.  Previous work in support of 
these relationships was conducted primarily with paradoxical or psychophysiologic insomnia 
samples and represent extreme ends on a continuum of sleep misperception (Fernandez-Mendoza 
et al., 2011; Vgontzas et al., 2013).  As such, it is possible that mental and physical health may 
predict sleep misperception only among the most severe cases which were not represented in the 
Primary Care patient sample of the present study. 
Pre-post changes in self-reported sleep, mood, and health were examined as a secondary 
aim in this study.  Statistically significant improvements in depression, anxiety, mental health 
functioning, and insomnia symptom severity were observed at one-week follow-up.  Daytime 
sleepiness and physical health functioning both remained relatively unchanged, falling within a 
normal range at baseline and follow-up.  Dysfunctional sleep beliefs did not change significantly 
from baseline to follow-up.  Overall, these findings suggest that a single-session corrective sleep 
feedback intervention is associated with improvements in self-reported sleep, mood, anxiety, and 
mental health functioning.  
Limitations.  The present study has some notable limitations.  This study did not include 
a control group to compare response to intervention, as such, improvements in secondary 
outcomes of depression, anxiety, and mental health functioning should be interpreted with 
caution as they may just represent the passage of time.  Further, findings are restricted to short-
term follow-up in this study.  Longitudinal studies are needed to evaluate intermediate and long-
term effects of corrective feedback on sleep perception, sleep-related distress, and objectively 
measured sleep.  Longer-term follow up would also provide an opportunity to explore the 
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potential preventive impact of corrective feedback, examining if there may be a buffering effect 
on a population health level within medical practices.  Such effects have been reported for 
corrective feedback when applied to other health behaviors (Dotson, Bowers, & Dunn, 2015).  A 
relatively small sample was included in this study, limiting statistical power.  Future research 
should be conducted with larger samples.   
Challenges in using technology were also evident in the present study.  Early in the study 
it was apparent that there was a seemingly systematic error with the Fitbits which resulted in the 
first night of data not being recorded for most participants.  This issue was not able to be 
resolved during the course of the study and, though the majority of participants were able to 
successfully record at least five nights of data, this highlights the continued challenges of 
conducting research using consumer devices.     
Moreover, consumer actigraphs are limited in measurement precision, however, they 
provide greater ecological validity in evaluating the utility of patient-generated health data 
(PGHD) in clinical practice.  It is important to note that future research and clinical practice 
should seriously consider this and employ such consumer-grade products within the context of 
this limitation.  Systemic issues and limitations should also be considered as the field continues 
to develop and explore the clinical utility of consumer devices and PGHD.  Probably most 
important is the question of standardization. 
Future Directions.  Though participants were instructed to wear the Fitbit a minimum of 
one hour before bed until one hour after waking, they were encouraged to wear the device 
throughout the day if they were so inclined.  It would be interesting to explore differences 
between those who elected to wear the Fitbit all day to track steps, activity, or heart rate and 
those who wore it only during required periods, as this may elucidate differences in engagement 
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and may offer insight into the target users who may benefit from technology-driven interventions 
for multiple health behavior change.  Researchers should consider evaluating overall engagement 
with consumer devices in future studies, as participants who are more invested may be more 
likely to engage in self-management and take a more active role in their own health and 
wellbeing.  
Research should not only explore the viability of consumer devices for assessing and 
intervening on sleep pathology but should also examine their potential as a tool for promoting 
and maintaining sleep health.  This framework is particularly attractive from a population and 
public health perspective.  Moreover, given the typical developmental course from acute to 
chronic sleep disturbance and insomnia, a health promotion approach seems to be a promising 
prevention effort worth further consideration.
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The Insomnia Severity Index 
Please rate the current (i.e., last 2 weeks) severity of your insomnia problem(s). 
  None Mild Moderate Severe Very 
a. Difficulty falling asleep: 0 1 2 3 4 
b. Difficulty staying asleep: 0 1 2 3 4 
c. Problem waking up too 
early: 
0 1 2 3 4 
 
How satisfied/dissatisfied are you with your current sleep pattern? 
Very satisfied Satisfied Neutral Dissatisfied Very dissatisfied 
0 1 2 3 4 
To what extent do you consider your sleep problem to interfere with your daily functioning (e.g., 
daytime fatigue, ability to function at work/daily chores, concentration, memory, mood, etc.)? 
 
Not at all 
interfering 
A little Somewhat Much Very much 
interfering 
 
0 1 2 3 4 
How noticeable to others do you think your sleeping problem is in terms of impairing the quality 
of your life? 
 
Not at all 
noticeable 
A little Somewhat Much Very much 
noticeable 
 
0 1 2 3 4 
How worried/distressed are you about your current sleep problem? 
Not at all 
worried 
A little Somewhat Much Very much 
worried 
 








Beliefs About Sleep 
Several statements reflecting people’s beliefs and attitudes about sleep are listed below.  
Please indicate (by circling the number) to what extent you personally agree or disagree with 
each statement.  There is no right or wrong answer.  For each statement, circle a number that 
best reflects your personal experience. Consider the whole scale, rather than only the 
extremes of the continuum. 
1. I need 8 hours of sleep to feel refreshed 
and function well during the day. 
Strongly 
Disagree 
           
Strongly 
Agree 
0 1 2 3 4 5 6 7 8 9 10 
           
 
2. When I do not get proper amount of 
sleep on a given night, I need to catch up 
on the next day by napping or on the 
next night by sleeping longer. 
Strongly 
Disagree 
           
Strongly 
Agree 
0 1 2 3 4 5 6 7 8 9 10 
           
 
3. I am concerned that chronic insomnia 




           
Strongly 
Agree 
0 1 2 3 4 5 6 7 8 9 10 
           
 
4. I am worried that I may lose control over 
my abilities to sleep. 
Strongly 
Disagree 
           
Strongly 
Agree 0 1 2 3 4 5 6 7 8 9 10 
           
 
5. After a poor night’s sleep, I know that it 
will interfere with my daily activities on 
the next day. 
Strongly 
Disagree 
           
Strongly 
Agree 
0 1 2 3 4 5 6 7 8 9 10 
           
 
6. In order to be alert and function well 
during the day, I am better off taking a 




           
Strongly 
Agree 
0 1 2 3 4 5 6 7 8 9 10 
           
 
7. When I feel irritable, depressed, or 
anxious during the day, it is mostly 




           
Strongly 
Agree 
0 1 2 3 4 5 6 7 8 9 10 
           
 
8. When I sleep poorly on one night, I know 
that it will disturb my sleep schedule for 
the whole week. 
Strongly 
Disagree 
           
Strongly 
Agree 
0 1 2 3 4 5 6 7 8 9 10 
           
 
9. Without an adequate night’s sleep, I can 
hardly function the next day. 
Strongly 
Disagree 
           
Strongly 
Agree 
0 1 2 3 4 5 6 7 8 9 10 
           
 
10. I can’t ever predict whether I will have a 
good or poor night’s sleep. 
Strongly 
Disagree 
           
Strongly 
Agree 0 1 2 3 4 5 6 7 8 9 10 
           
 
11. I have little ability to manage the 




           
Strongly 
Agree 
0 1 2 3 4 5 6 7 8 9 10 
           
 
 
12. When I feel tired, have no energy, or just Strongly 




seem not to function well during the day, 
it is generally because I did not sleep 
well the night before. 
Disagree 0 1 2 3 4 5 6 7 8 9 10 Agree 
           
 
13. I believe that insomnia is essentially a 
result of a chemical imbalance. 
Strongly 
Disagree 
           
Strongly 
Agree 
0 1 2 3 4 5 6 7 8 9 10 
           
 
14. I feel that insomnia is ruining my ability to 
enjoy life and prevents me from doing 
what I want. 
Strongly 
Disagree 
           
Strongly 
Agree 
0 1 2 3 4 5 6 7 8 9 10 
           
 




           
Strongly 
Agree 
0 1 2 3 4 5 6 7 8 9 10 
           
 
16. I avoid or cancel obligations (social, 




           
Strongly 
Agree 
0 1 2 3 4 5 6 7 8 9 10 




















Your Health and Well-Being 
 
 
This survey asks for your views about your health.  This information will 
help keep track of how you feel and how well you are able to do your usual 
activities. Thank you for completing this survey! 
 
For each of the following questions, please mark an  in the one box that best 
describes your answer. 
 
1. In general, would you say your health is: 
Excellent Very good Good Fair Poor 
    




2. Compared to one week ago, how would you rate your health in general 
now? 
Much better 




now than one 
week ago 
About the 




now than one 
week ago 
Much worse 
now than one 
week ago 
    
   1    2    3    4    5 
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3. The following questions are about activities you might do during a typical 
day.  Does your health now limit you in these activities?  If so, how much?  
 
 









    
 a Vigorous activities, such as running, lifting  
heavy objects, participating in strenuous sports ......................  1 .............  2 .............  3 
 b Moderate activities, such as moving a table, pushing  
a vacuum cleaner, bowling, or playing golf.............................  1 .............  2 .............  3 
 c Lifting or carrying groceries ....................................................  1 .............  2 .............  3 
 d Climbing several flights of stairs .............................................  1 .............  2 .............  3 
 e Climbing one flight of stairs ....................................................  1 .............  2 .............  3 
 f Bending, kneeling, or stooping ................................................  1 .............  2 .............  3 
 g Walking more than a mile ........................................................  1 .............  2 .............  3 
 h Walking several hundred yards ...............................................  1 .............  2 .............  3 
 i Walking one hundred yards .....................................................  1 .............  2 .............  3 
 j Bathing or dressing yourself ....................................................  1 .............  2 .............  3 
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4. During the past week, how much of the time have you had any of the 
following problems with your work or other regular daily activities as a 
result of your physical health? 
 All of  
the time 
Most of  
the time 
Some of  
the time 




     
 a Cut down on the amount of  
time you spent on work or  
other activities ..................................  1 ..............  2 ..............  3 ..............  4 .............  5 
 b Accomplished less than you  
would like ........................................  1 ..............  2 ..............  3 ..............  4 .............  5 
 c Were limited in the kind of  
work or other activities ....................  1 ..............  2 ..............  3 ..............  4 .............  5 
 d Had difficulty performing the  
work or other activities (for  
example, it took extra effort) ...........  1 ..............  2 ..............  3 ..............  4 .............  5 
 
 
5. During the past week, how much of the time have you had any of the 
following problems with your work or other regular daily activities as a 
result of any emotional problems (such as feeling depressed or anxious)? 
 All of  
the time 
Most of  
the time 
Some of  
the time 




     
 a Cut down on the amount of  
time you spent on work or  
other activities ..................................  1 ..............  2 ..............  3 ..............  4 .............  5 
 b Accomplished less than you  
would like ........................................  1 ..............  2 ..............  3 ..............  4 .............  5 
 c Did work or other activities  
less carefully than usual ...................  1 ..............  2 ..............  3 ..............  4 .............  5 
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6. During the past week, to what extent has your physical health or 
emotional problems interfered with your normal social activities with 
family, friends, neighbors, or groups? 
Not at all Slightly Moderately Quite a bit Extremely 
    






7. How much bodily pain have you had during the past week? 
None Very mild Mild Moderate Severe Very severe 
     






8. During the past week, how much did pain interfere with your normal 
work (including both work outside the home and housework)? 
Not at all A little bit Moderately Quite a bit Extremely 
    
   1    2    3    4    5 
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9. These questions are about how you feel and how things have been with 
you during the past week.  For each question, please give the one answer 
that comes closest to the way you have been feeling.  How much of the time 
during the past week… 
 
10. During the past week, how much of the time has your physical health or 
emotional problems interfered with your social activities (like visiting with 
friends, relatives, etc.)? 
All of  
the time 
Most of  
the time 
Some of  
the time 




    
   1    2    3    4    5 
 
 
 All of  
the time 
Most of  
the time 
Some of  
the time 




     
 a Did you feel full of life? ..................  1 ..............  2 ..............  3 ..............  4 ..............  5 
 b Have you been very nervous? ..........  1 ..............  2 ..............  3 ..............  4 ..............  5 
 c Have you felt so down in the  
dumps that nothing could  
cheer you up? ...................................  1 ..............  2 ..............  3 ..............  4 ..............  5 
 d Have you felt calm and  
peaceful? ..........................................  1 ..............  2 ..............  3 ..............  4 ..............  5 
 e Did you have a lot of energy? ..........  1 ..............  2 ..............  3 ..............  4 ..............  5 
 f Have you felt downhearted   
and depressed? .................................  1 ..............  2 ..............  3 ..............  4 ..............  5 
 g Did you feel worn out? ....................  1 ..............  2 ..............  3 ..............  4 ..............  5 
 h Have you been happy? .....................  1 ..............  2 ..............  3 ..............  4 ..............  5 
 i Did you feel tired? ...........................  1 ..............  2 ..............  3 ..............  4 ..............  5 
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     
 a I seem to get sick a little 
easier than other people ..................  1 ..............  2 .............  3...............  4 ..............  5 
 b I am as healthy as  
anybody I know ..............................  1 ..............  2 .............  3...............  4 ..............  5 
 c I expect my health to  
get worse .........................................  1 ..............  2 .............  3...............  4 ..............  5 











































What is a Sleep Diary? A sleep diary is designed to gather information about your daily sleep pattern. 
 
How often and when do I fill out the sleep diary? It is necessary for you to complete your sleep diary every 
day.  If possible, the sleep diary should be completed within one hour of getting out of bed in the morning. The 
Nighttime Sleep Diary questions can be completed before you go to bed at night. 
 
What should I do if I miss a day?  If you forget to fill in the diary or are unable to finish it, leave the diary blank 
for that day. 
 
What if something unusual affects my sleep or how I feel in the daytime? If your sleep or daytime 
functioning is affected by some unusual event (such as an illness, or an emergency) you may make brief notes 
on your diary. 
 
What do the words “bed” and “day” mean on the diary? This diary can be used for people who are awake or 
asleep at unusual times. In the sleep diary, the word “day” is the time when you choose or are required to be 
awake. The term “bed” means the place where you usually sleep. 
 
Will answering these questions about my sleep keep me awake? This is not usually a problem. You should 
not worry about giving exact times, and you should not watch the clock. Just give your best estimate. 
 
Morning Sleep Diary Item Instructions 
 
Use the guide below to clarify what is being asked for each item of the Sleep Diary. 
Date: Write the date of the morning you are filling out the diary. 
1. What time did you get into bed? Write the time that you got into bed. This may not be the time you 
began “trying” to fall asleep. 
2. What time did you try to go to sleep? Record the time that you began “trying” to fall asleep. 
3. How long did it take you to fall asleep? Beginning at the time you wrote in question 2, how long did it 
take you to fall asleep. 
4. How many times did you wake up, not counting your final awakening? How many times did you wake up 
between the time you first fell asleep and your final awakening? 
5. In total, how long did these awakenings last? What was the total time you were awake between the 
time you first fell asleep and your final awakening. For example, if you woke 3 times for 20 minutes, 35 
minutes, and 15 minutes, add them all up (20+35+15= 70 min or 1 hr and 10 min). 
6a. What time was your final awakening? Record the last time you woke up in the morning. 
6b. After your final awakening, how long did you spend in bed trying to sleep? After the last time you woke-up 
(Item #6a), how many minutes did you spend in bed trying to sleep? For example, if you woke up at 8 am but 
continued to try and sleep until 9 am, record 1 hour. 
6c. Did you wake up earlier than you planned? If you woke up or were awakened earlier than you planned, 
check yes. If you woke up at your planned time, check no. 
6d. If yes, how much earlier? If you answered “yes” to question 6c, write the number of minutes you woke 
up earlier than you had planned on waking up. For example, if you woke up 15 minutes before the alarm 






7. What time did you get out of bed for the day? What time did you get out of bed with no further attempt 
at sleeping? This may be different from your final awakening time (e.g. you may have woken up at   
6:35 a.m. but did not get out of bed to start your day until 7:20 a.m.) 
8. In total, how long did you sleep? This should just be your best estimate, based on when you went to 
bed and woke up, how long it took you to fall asleep, and how long you were awake.  You do not need 
to calculate this by adding and subtracting; just give your best estimate. 
9. How would you rate the quality of your sleep?  “Sleep Quality” is your sense of whether your sleep 
was good or poor. 
10. How restful or refreshed did you feel when you woke up for the day? This refers to how you felt after 
you were done sleeping for the night, during the first few minutes that you were awake. 
 
 
Nighttime Sleep Diary Item Instructions 
Please complete the following items before you go to bed. 
Date: Write the date of the evening you are filling out the diary. 
11a. How many times did you nap or doze? A nap is a time you decided to sleep during the day, 
whether in bed or not in bed. “Dozing” is a time you may have nodded off for a few minutes, without 
meaning to, such as while watching TV. Count all the times you napped or dozed at any time from 
when you first got out of bed in the morning until you got into bed again at night. 
11b. In total, how long did you nap or doze? Estimate the total amount of time you spent napping or 
dozing, in hours and minutes. For instance, if you napped twice, once for 30 minutes and once for 60 
minutes, and dozed for 10 minutes, you would answer “1 hour 40 minutes.” If you did not nap or doze, 
write “N/A” (not applicable). 
12a. How many drinks containing alcohol did you have? Enter the number of alcoholic drinks you had 
where 1 drink is defined as one 12 oz beer (can), 5 oz wine, or 1.5 oz liquor (one shot). 
12b. What time was your last drink? If you had an alcoholic drink yesterday, enter the time of day in 
hours and minutes of your last drink. If you did not have a drink, write “N/A” (not applicable). 
13a. How many caffeinated drinks (coffee, tea, soda, energy drinks) did you have? Enter the number 
of caffeinated drinks (coffee, tea, soda, energy drinks) you had where for coffee and tea, one drink = 
6-8 oz; while for caffeinated soda one drink = 12 oz. 
13b. What time was your last drink? If you had a caffeinated drink, enter the time of day in hours and 
minutes of your last drink. If you did not have a caffeinated drink, write “N/A” (not applicable). 
14. Did you take any over-the-counter or prescription medication(s) to help you sleep? If so, list 
medication(s), dose, and time taken: List the medication name, how much and when you took EACH 
different medication you took tonight to help you sleep.  Include medication available over the counter, 
prescription medications, and herbals (example: "Sleepwell 50 mg 11 pm").  If every night is the same, 
write “same” after the first day 
15. Comments If you have anything that you would like to say that is relevant to your sleep feel free to 
























I believe the Fitbit Charge HR™ accurately measured my sleep 
patterns. 
    
2 The Fitbit Charge HR™ was easy to use.     
3 
I plan to purchase a Fitbit™ or another sleep monitoring device 
after participating in this study. 
    
4 
I have a better understanding of my sleep patterns after 
participating in this study. 
    
5 The personalized sleep feedback was informative.     
6 The personalized sleep feedback was useful.     
7 
I would recommend this study to a friend or family member 
with sleep problems. 
    
8 
I would like for my physician to use consumer technology 
products (e.g., Fitbit™, mobile apps) as a part of routine care. 
    
 










Sleep Feedback Report 
 
 
The following feedback report is based on behavioral sleep measurement data collected from the 
Fitbit Charge HR over the course of one week. This device uses accelerometer technology to 
detect your movement and activity level during sleep. Your sleep data was extracted and 
analyzed in 60-second increments using a specialized research platform to provide a reliable 
estimate of your sleep pattern. Below is a summary and a graphic illustration of your sleep data.   
 
During the nights when you wore the Fitbit, the average time you fell asleep was 11:31 PM and 
your average total sleep duration was 6 hours and 38 minutes, with total sleep time ranging from 
6 hours and 15 minutes to 7 hours and 1 minute. In contrast, during your initial visit (xx/xx/xx) 
you estimated that you sleep approximately 4 hours and 30 minutes per night, on average. Based 
on your sleep diary, you reported sleeping an average of 5 hours and 36 minutes per night during 
the past week. Taken together these results indicate that, on average you slept 56 minutes more 
per night than you thought during the past week (based on sleep diary) and approximately 2 
hours and 8 minutes more per night than you estimated at your initial visit. The National Sleep 
Foundation recommends that adults sleep at least 7 hours per night and based on this standard 
your sleep results indicate that you are generally getting slightly less than adequate sleep.  
 
When taking into consideration all 6 nights of recording, the total amount of time you spent 
awake after initially falling asleep was 1 hour and 43 minutes and this amount ranged from 9 
minutes to 26 minutes per night. Results also indicated that you were quite restless, with an 
average of 34 restless minutes per night and a total of 3 hours and 24 minutes of restlessness 
across all 6 nights.  
   
Overall, results of your sleep assessment suggest that you sleep more hours per night than you 
expected and that you are receiving an inadequate amount of sleep on average. Also, your sleep 
is very fragmented and restless throughout the night. 
 
 
Keri Dotson, M.S.        









Disclaimer: The data presented herein were collected using the Fitbit Charge HR™ as part of a research study for 
which you volunteered to participate. The Fitbit Charge HR™ is not a medical device and has not been evaluated by 
the FDA for this purpose. This report aims to provide an exploratory interpretation based on data collected from the 
Fitbit™ for research purposes. The information provided in this report does not constitute a medical diagnosis or 
medical advice and is not intended to be a substitute for professional medical treatment. Do not disregard 
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